<?xml version="1.0" encoding="UTF-8"?>
<ref id="B76-pharmaceuticals-12-00101">
 <label>76.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Brecher</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Deng</surname>
    <given-names>Y.Q.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Sakamuru</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Koetzner</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Allen</surname>
    <given-names>C.A.</given-names>
   </name>
   <name>
    <surname>Jones</surname>
    <given-names>S.A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction</article-title>
  <source>Cell Res.</source>
  <year>2017</year>
  <volume>27</volume>
  <fpage>1046</fpage>
  <lpage>1064</lpage>
  <pub-id pub-id-type="doi">10.1038/cr.2017.88</pub-id>
  <?supplied-pmid 28685770?>
  <pub-id pub-id-type="pmid">28685770</pub-id>
 </element-citation>
</ref>
